Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market for common stock
The principal trading market for the Company’s common stock is the Global Select Market of The Nasdaq Stock Market LLC. The Company’s common stock trades under the symbol “INDV.”
Holders
Based upon information supplied from our transfer agent, there were approximately 139 stockholders of record of our common stock as of January 31, 2026.
Dividends
We have not paid any dividends during the past three fiscal years and do not anticipate declaring or paying any cash dividends on our common stock in the foreseeable future. Until January 23, 2026, we were incorporated under the laws of England and Wales and, under English law, any payment o f dividends would be subject to relevant legislation and our articles of association, which provide that payment of dividends be approved by our Board of Directors and, in some cases, our stockholders, and may only be paid from our distributable earnings available for the purpose, determined on an unconsolidated basis.
Five-Year Common Stock Performance
The following graph and table compare the cumulative total shareholder return of the Company’s common stock, the S&P 600 SmallCap Index, and the Nasdaq Biotech Index for the five-year period ended December 31, 2025. The Company is a component of both indexes. T he graph and table assume an initial investment of $100 was made on December 31, 2020 in each of the Company’s common stock and the two indexes, as well as reinvestment of all dividends without commissions.
80
Cumulative Total Stockholder Return
Amount Invested
Cumulative Total Return
As of/Through Dec. 31
2020 2021 2022 2023 2024 2025
Indivior
$ 100.00 $ 233.85 $ 301.40 $ 205.42 $ 167.21 $ 483.00
S&P 600 SmallCap Index $ 100.00 $ 126.77 $ 105.22 $ 119.71 $ 127.93 $ 133.00
Nasdaq Biotech Index $ 100.00 $ 100.48 $ 89.63 $ 92.95 $ 91.74 $ 121.00
Recent Sales of Unregistered Securities
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchases
Period
Total Number of shares purchased
Average price paid per share
Total number of shares purchased as part of publicly announced plans or programs
Maximum number of shares that may yet be purchased under the plans or programs
Oct. 1 to Oct. 31
0
n/a
0
0
Nov. 1 to Nov. 30
0
n/a
0
0
Dec. 1 to Dec. 31
0
n/a
0
0
Item 6. [Reserved]
Not applicable.
81
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.